Search Results - "Bollen, D."

Explaining the effects of processing on the electrical properties of PEDOT:PSS by VAN REENEN, S, SCHEEPERS, M, VAN DE RUIT, K, BOLLEN, D, KEMERINK, M

“…By simultaneously measuring the Seebeck coefficient and the conductivity in differently processed PEDOT:PSS films, fundamental understanding is gained on how…”
Get full text

Overview of the Opportunity Mars Exploration Rover Mission to Meridiani Planum: Eagle Crater to Purgatory Ripple by Squyres, S. W., Arvidson, R. E., Bollen, D., Bell, J. F., Brückner, J., Cabrol, N. A., Calvin, W. M., Carr, M. H., Christensen, P. R., Clark, B. C., Crumpler, L., Des Marais, D. J., d'Uston, C., Economou, T., Farmer, J., Farrand, W. H., Folkner, W., Gellert, R., Glotch, T. D., Golombek, M., Gorevan, S., Grant, J. A., Greeley, R., Grotzinger, J., Herkenhoff, K. E., Hviid, S., Johnson, J. R., Klingelhöfer, G., Knoll, A. H., Landis, G., Lemmon, M., Li, R., Madsen, M. B., Malin, M. C., McLennan, S. M., McSween, H. Y., Ming, D. W., Moersch, J., Morris, R. V., Parker, T., Rice, J. W., Richter, L., Rieder, R., Schröder, C., Sims, M., Smith, M., Smith, P., Soderblom, L. A., Sullivan, R., Tosca, N. J., Wänke, H., Wdowiak, T., Wolff, M., Yen, A.

“…The Mars Exploration Rover Opportunity touched down at Meridiani Planum in January 2004 and since then has been conducting observations with the Athena science…”
Get full text

Percutaneous bone‐anchored hearing system implant survival after 550 primary implant surgeries by Calon, T.G.A., Tongeren, J., Heuft, A.M.E., Brunings, J.W., Bollen, D., Hof, J.R., Stokroos, R.J.

Get full text

Development and validation of an UPLC-MS/MS bioanalytical method for simultaneous quantification of the antiretroviral drugs dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine in human plasma by Bollen, Pauline D.J., de Graaff-Teulen, Marga J.A., Schalkwijk, Stein, van Erp, Nielka P., Burger, David M.

“…Dolutegravir, elvitegravir, raltegravir, nevirapine and etravirine are antiretroviral drugs used as part of combined antiretroviral treatment for…”
Get full text

Influence of age and co‐medication on dolutegravir glucuronidation in paediatric patients by Jacobs, Tom G., Waalewijn, Hylke, Houlden, Lily, Bollen, Pauline D. J., Nanduudu, Annet, Nambi, Esether, Cassim, Haseena, Lugemwa, Abbas, Makumbi, Shafic, Monkiewicz, Lara N., Shakeshaft, Clare, Bamford, Alasdair, Archary, Moherndran, Musuro, Godfrey, Chidziva, Ennie, Mujuru, Hilda A., Bwakura‐Dangarembizi, Mutsa, Chabala, Chishala, Turkova, Anna, Gibb, Di M., Cotton, Mark F., Aarnoutse, Rob, Burger, David M., Colbers, Angela

“…Dolutegravir (DTG) is primarily metabolized by uridine diphosphate glucuronosyltransferases, forming the pharmacologically inactive DTG glucuronide (DTG‐gluc)…”
Get full text

Complementary Medicines Regulatory Reform by Bollen, Michael D, Whicker, Susan D

“…Australians are being encouraged to take greater responsibility for their own health care. The concept of self-care is being promoted widely, including the…”
Get full text

The dolutegravir/valproic acid drug–drug interaction is primarily based on protein displacement by Bollen, P D J, Prins, H A B, Colbers, A, Velthoven-Graafland, K, Rijnders, B J A, de Vries-Sluijs, T E M S, van Nood, E, Nouwen, J, Bax, H, de Mendonca Melo, M, Verbon, A, Burger, D M, Rokx, C

“…Abstract Objectives The dolutegravir/valproic acid drug–drug interaction (DDI) is suggested to be caused by protein displacement. Here, we assess the…”
Get full text

Growth Mechanism of Vapor-Grown Silver Crystals:  Relation between Twin Formation and Morphology by Bögels, G, Meekes, H, Bennema, P, Bollen, D

“…This study deals with the morphology and growth mechanism of multiply twinned Ag crystals grown from the vapor phase. Ag crystals were grown under sublimation…”
Get full text

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial by Waalewijn, Hylke, Chan, Man K, Bollen, Pauline D J, Mujuru, Hilda A, Makumbi, Shafic, Kekitiinwa, Adeodata R, Kaudha, Elizabeth, Sarfati, Tatiana, Musoro, Godfrey, Nanduudu, Annet, Lugemwa, Abbas, Amuge, Pauline, Moore, Cecilia L, Rojo, Pablo, Giaquinto, Carlo, Colbers, Angela, Gibb, Diana M, Ford, Deborah, Turkova, Anna, Burger, David M

“…Dolutegravir-based antiretroviral therapy is a preferred first-line treatment for adults and children living with HIV; however, very little pharmacokinetic…”
Get full text

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial by Bollen, Pauline D J, Moore, Cecilia L, Mujuru, Hilda A, Makumbi, Shafic, Kekitiinwa, Adeodata R, Kaudha, Elisabeth, Parker, Anna, Musoro, Godfrey, Nanduudu, Annet, Lugemwa, Abbas, Amuge, Pauline, Hakim, James G, Rojo, Pablo, Giaquinto, Carlo, Colbers, Angela, Gibb, Diana M, Ford, Deborah, Turkova, Anna, Burger, David M

“…Paediatric dolutegravir doses approved by stringent regulatory authorities (SRAs) for children weighing 20 kg to less than 40 kg until recently required 25 mg…”
Get full text

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial by Turkova, Anna, Waalewijn, Hylke, Chan, Man K, Bollen, Pauline D J, Bwakura-Dangarembizi, Mutsa F, Kekitiinwa, Adeodata R, Cotton, Mark F, Lugemwa, Abbas, Variava, Ebrahim, Ahimbisibwe, Grace Miriam, Srirompotong, Ussanee, Mumbiro, Vivian, Amuge, Pauline, Zuidewind, Peter, Ali, Shabinah, Kityo, Cissy M, Archary, Moherndran, Ferrand, Rashida A, Violari, Avy, Gibb, Diana M, Burger, David M, Ford, Deborah, Colbers, Angela

“…Children with HIV-associated tuberculosis (TB) have few antiretroviral therapy (ART) options. We aimed to evaluate the safety and pharmacokinetics of…”
Get full text

Dolutegravir is not removed during hemodialysis by Bollen, Pauline D.J, Rijnders, Bart J.A, Teulen, Marga J.A, Burger, David M

Get full text

The role of {1 0 0} side faces for lateral growth of tabular silver bromide crystals by Bögels, G, Meekes, H, Bennema, P, Bollen, D

“…In this study the growth of {1 1 1} tabular silver bromide crystals will be examined in situ under different conditions to determine a general growth…”
Get full text

Morphology of silver bromide crystals from KBr–AgBr–DMSO–water systems by Millan, A, Bennema, P, Verbeeck, A, Bollen, D

“…The morphology of crystals precipitated from silver bromide complex solutions in organic solvents has been studied by scanning electron microscopy. {1 0 0}, {1…”
Get full text

Recent changes in Australian general practice by Bollen, M D

Get more information

Morphology and growth mechanism of multiply twinned AgBr and AgCl needle crystals by Bögels, G, Buijnsters, J.G, Verhaegen, S.A.C, Meekes, H, Bennema, P, Bollen, D

“…In this study the morphology and growth mechanism of AgX (X=Cl, Br) needle crystals will be revealed. The silver halide needles are grown by two different…”
Get full text

Side-Face Structure and Growth Mechanism of Tabular Silver Bromide Crystals by Bögels, G., Pot, T. M., Meekes, H., Bennema, P., Bollen, D.

Get full text

Mirror exposure reduces body dissatisfaction and anxiety in obese adolescents: A pilot study by Jansen, Anita, Bollen, Dafne, Tuschen-Caffier, Brunna, Roefs, Anne, Tanghe, Ann, Braet, Caroline

“…Many obese adolescents show intense body shape and weight concerns that render them vulnerable to cognitive biases, psychological distress and eating…”
Get full text

Shear cutting of PET film by BOLLEN, D, DENEIR, J, AERNOUDT, E, MUYLLE, W

“…Poly(ethylene terephthalate) (PET) film was extruded and then successively biaxially stretched and thermofixed to obtain a high-strength film with stable…”
Get full text

Complementary Medicines Regulatory Reform by Michael D Bollen, Susan D Whicker

“…Australians are being encouraged to take greater responsibility for their own health care. The concept of self-care is being promoted widely, including the…”
Get full text